The University of Southampton
University of Southampton Institutional Repository

Screening tools used for measuring depression among people with Type 1 and Type?2 diabetes: a systematic review.

Screening tools used for measuring depression among people with Type 1 and Type?2 diabetes: a systematic review.
Screening tools used for measuring depression among people with Type 1 and Type?2 diabetes: a systematic review.
Background:? Depression is common in patients with Type 1 or Type 2 diabetes, has a strong negative impact on the quality of life of patients and is associated with poor outcomes and higher mortality rates. Several guidelines encourage screening of patients with diabetes for depression. It is unclear which depression screening tools are currently being used in people with diabetes and which are most appropriate.

Methods:? A systematic review was conducted to examine which depression screening instruments are currently being used in diabetes research, and the operating characteristics of these tools in diabetes populations. Literature searches for the period January 1970 to October 2010 were conducted using MEDLINE, PSYCH-INFO, ASSIA, SCOPUS, ACADEMIC SEARCH COMPLETE, CINAHL and SCIENCE DIRECT.

Results:? Data are presented for the 234 published studies that were examined. The Beck Depression Inventory and the Centre for Epidemiologic Studies Depression Scale were the most popular screening tools (used in 24% and 21% of studies). Information on the cultural applicability of screening tools was mostly unavailable and, where reported, included only details of the language translation process. A small number of studies reported reliability data, most of which showed moderate–good sensitivity and specificity but a high rate of false positives.

Conclusions:? Although a range of depression screening tools have been used in research, there remains few data on their reliability and validity. Information on the cultural applicability of these instruments is even scantier. Further research is required in order to determine the suitability of screening tools for use in clinical practice and to address the increasing problem of co-morbid diabetes and depression.
depression, diabetes, screening tools
0742-3071
164-75
Roy, T.
9ab6153b-36c7-4e91-a2a3-9cdabbba4988
Lloyd, C.E.
dbdee3fe-a74b-456b-b24b-4f90834ef8e0
Pouwer, F.
1bf90039-859a-487f-9276-3e8c103eeeef
Holt, R.I.G.
d54202e1-fcf6-4a17-a320-9f32d7024393
Sartorius, N.
1d07d5ad-26c3-48e7-b7c7-52120bf89222
Roy, T.
9ab6153b-36c7-4e91-a2a3-9cdabbba4988
Lloyd, C.E.
dbdee3fe-a74b-456b-b24b-4f90834ef8e0
Pouwer, F.
1bf90039-859a-487f-9276-3e8c103eeeef
Holt, R.I.G.
d54202e1-fcf6-4a17-a320-9f32d7024393
Sartorius, N.
1d07d5ad-26c3-48e7-b7c7-52120bf89222

Roy, T., Lloyd, C.E., Pouwer, F., Holt, R.I.G. and Sartorius, N. (2012) Screening tools used for measuring depression among people with Type 1 and Type?2 diabetes: a systematic review. Diabetic Medicine, 29 (2), 164-75. (doi:10.1111/(ISSN)1464-5491). (PMID:21824180)

Record type: Article

Abstract

Background:? Depression is common in patients with Type 1 or Type 2 diabetes, has a strong negative impact on the quality of life of patients and is associated with poor outcomes and higher mortality rates. Several guidelines encourage screening of patients with diabetes for depression. It is unclear which depression screening tools are currently being used in people with diabetes and which are most appropriate.

Methods:? A systematic review was conducted to examine which depression screening instruments are currently being used in diabetes research, and the operating characteristics of these tools in diabetes populations. Literature searches for the period January 1970 to October 2010 were conducted using MEDLINE, PSYCH-INFO, ASSIA, SCOPUS, ACADEMIC SEARCH COMPLETE, CINAHL and SCIENCE DIRECT.

Results:? Data are presented for the 234 published studies that were examined. The Beck Depression Inventory and the Centre for Epidemiologic Studies Depression Scale were the most popular screening tools (used in 24% and 21% of studies). Information on the cultural applicability of screening tools was mostly unavailable and, where reported, included only details of the language translation process. A small number of studies reported reliability data, most of which showed moderate–good sensitivity and specificity but a high rate of false positives.

Conclusions:? Although a range of depression screening tools have been used in research, there remains few data on their reliability and validity. Information on the cultural applicability of these instruments is even scantier. Further research is required in order to determine the suitability of screening tools for use in clinical practice and to address the increasing problem of co-morbid diabetes and depression.

This record has no associated files available for download.

More information

Published date: February 2012
Keywords: depression, diabetes, screening tools
Organisations: Human Development & Health

Identifiers

Local EPrints ID: 201297
URI: http://eprints.soton.ac.uk/id/eprint/201297
ISSN: 0742-3071
PURE UUID: d64904d3-cdbf-44a5-b011-3c2657e99e9d
ORCID for R.I.G. Holt: ORCID iD orcid.org/0000-0001-8911-6744

Catalogue record

Date deposited: 28 Oct 2011 12:53
Last modified: 15 Mar 2024 03:08

Export record

Altmetrics

Contributors

Author: T. Roy
Author: C.E. Lloyd
Author: F. Pouwer
Author: R.I.G. Holt ORCID iD
Author: N. Sartorius

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×